Germany
Japan
United Kingdom
China
Antibodies
Download
USD 390.00
In Stock
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HC10, Purified
| Applications | ELISA, EM, FC, IF, IHC, IP, WB |
| Reactivities | Human |
H2-D1 mouse monoclonal antibody, clone 28-14-8, Purified
| Applications | CT, FC, FN, IHC, IP |
| Reactivities | Mouse |
USD 250.00
2 Weeks
USD 415.00
2 Weeks
Adeno-associated Virus / AAV (VP1 + VP2 + VP3) mouse monoclonal antibody, clone B1, Purified
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Monkey |
USD 475.00
2 Weeks
USD 415.00
2 Weeks
Adeno-Associated Virus 2 / AAV2 (intact particle) mouse monoclonal antibody, clone A20, Purified
| Applications | ELISA, FN, IF, IHC, IP |
| Reactivities | Human, Monkey |
Cd28 hamster monoclonal antibody, clone 37.51, Purified
| Applications | FC, FN, IP |
| Reactivities | Mouse |
Pdpn hamster monoclonal antibody, clone 811, Purified
| Applications | IHC, IP, WB |
| Reactivities | Mouse |
HLA Class II DR mouse monoclonal antibody, clone L243, Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Primate |
USD 220.00
2 Weeks
p75 NGF Receptor (NGFR) (1-160) mouse monoclonal antibody, clone NGFR5, Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Feline, Ferret, Human, Monkey, Rabbit |
CD4 mouse monoclonal antibody, clone MEM-115, Azide Free
| Applications | FC, FN, IP, WB |
| Reactivities | Human |
USD 420.00
In Stock
Cd80 hamster monoclonal antibody, clone 16-10A1, Aff - Purified
| Applications | FC, FN, IHC, IP |
| Reactivities | Canine, Mouse |
USD 390.00
2 Weeks
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HCA2, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Tubulin (TUBA1B) (Tyr-Tubulin) rat monoclonal antibody, clone YL1/2, Purified
| Applications | ELISA, IF, IHC, IP, R, WB |
| Reactivities | Birds, Mammalian, Yeast |
EPCAM mouse monoclonal antibody, clone 323/A3, Aff - Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
CD3E mouse monoclonal antibody, clone MEM-92, Purified
| Applications | FC, FN, IP |
| Reactivities | Human |
CD82 mouse monoclonal antibody, clone C33, Aff - Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Human |
Aggrecan (ACAN) mouse monoclonal antibody, clone HAG7D4 (7D4), Purified
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Bovine, Human |
MITF mouse monoclonal antibody, clone C5, Purified
| Applications | EMSA, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
USD 395.00
2 Weeks
Adeno-Associated Virus 5 / AAV5 (intact particle) mouse monoclonal antibody, clone ADK5a, Aff - Purified
| Applications | ELISA, IF, IHC, IP, NEUT |
Tenascin C (TNC) mouse monoclonal antibody, clone T2H5, Purified
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
USD 220.00
2 Weeks
GM CSF Receptor alpha (CSF2RA) mouse monoclonal antibody, clone 4H1, Purified
| Applications | FC, IHC, IP, WB |
| Reactivities | Human |
USD 430.00
2 Weeks
Carbonic Anhydrase IX (CA9) Marker mouse monoclonal antibody, clone 66.4.C2 (PN-15), Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Equine, Human |
USD 240.00
2 Weeks
Carbonic Anhydrase IX (CA9) Marker mouse monoclonal antibody, clone 66.4.C2 (PN-15), Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Equine, Human |
CD13 (ANPEP) mouse monoclonal antibody, clone WM15, Purified
| Applications | ELISA, FC, FN, IHC, IP |
| Reactivities | Human, Primate |
CD41-CD61 Complex mouse monoclonal antibody, clone P2, Azide Free
| Applications | ELISA, FC, FN, IHC, IP |
| Reactivities | Human |
Mrc1 rat monoclonal antibody, clone MR5D3, Purified
| Applications | FC, IF, IHC, IP |
| Reactivities | Mouse |
LCK mouse monoclonal antibody, clone LCK-01, Purified
| Applications | FC, IF, IP, WB |
| Reactivities | Human |
PDPN rat monoclonal antibody, clone NZ-1, Purified
| Applications | FC, IHC, IP, WB |
| Reactivities | Human |
Ly-76 / TER-119 rat monoclonal antibody, clone TER-119, Purified
| Applications | FC, IHC, IP, WB |
| Reactivities | Mouse |
USD 270.00
5 Days
6xHistidine Epitope Tag (HHHHHH) mouse monoclonal antibody, clone AD1.1.10, Purified
| Applications | ELISA, IHC, IP, WB |
CD130 (IL6ST) mouse monoclonal antibody, clone B-P4, Azide Free
| Applications | FC, FN, IHC, IP, WB |
| Reactivities | Human |
Histone H1 mouse monoclonal antibody, clone AE-4, Purified
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human |
USD 815.00
5 Days
p53 (TP53) (16-25) mouse monoclonal antibody, clone BP53-12, Purified
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Primate |
IL3RA mouse monoclonal antibody, clone 6H6, Purified
| Applications | FC, IHC, IP, WB |
| Reactivities | Human |
Active filters
Category
-
Antibodies
- Primary Antibodies
Applications
- IP
Clonalities
- Monoclonal
Filter by
Target Symbol
- LIPG (105)
- BRAF (70)
- MAPK1 (54)
- FCGR2A (47)
- CRYAB (45)
- NEUROG1 (45)
- NRBP1 (45)
- RALBP1 (45)
- LTA4H (40)
- L1CAM (37)
- RPA2 (36)
- GBE1 (35)
- TYRO3 (35)
- PIM2 (30)
- PLK1 (30)
- SLC2A5 (30)
- SSB (30)
- CHEK2 (26)
- DAPK2 (25)
- SERPINA1 (25)
- LDHA (22)
- FERMT2 (20)
- LEMD3 (20)
- MAP2K4 (20)
- CAS9 (16)
- GAD1 (15)
- HDAC10 (15)
- NEK6 (15)
- USP13 (15)
- CD74 (11)
- AKT2 (10)
- DDK (10)
- SLC7A8 (10)
- TUBA8 (10)
- CD3E (9)
- NEUROG3 (9)
- CD8A (8)
- EGFR (8)
- MYC (8)
- BAX (7)
- CCR5 (7)
- CD40 (6)
- LTF (6)
- MAPK8 (6)
- NIPBL (6)
- GADD45G (5)
- IL2RA (5)
- MUC1 (5)
- PROM2 (5)
- SELL (5)
- SHC1 (5)
- SORD (5)
- TP53 (5)
- TUBA1B (5)
- ACTA1 (4)
- ADRB2 (4)
- AOC3 (4)
- CCRL2 (4)
- CD22 (4)
- CD27 (4)
- CD44 (4)
- CD86 (4)
- INSR (4)
- ITGB2 (4)
- MAPT (4)
- MHC I (4)
- MS4A4A (4)
- MSLN (4)
- TCR (4)
- VEGFA (4)
- APP (3)
- CBFA2T2 (3)
- CCR7 (3)
- CD28 (3)
- CD34 (3)
- CD80 (3)
- CD81 (3)
- CFI (3)
- CR2 (3)
- CYCS (3)
- EIF4E (3)
- EPCAM (3)
- HRAS (3)
- HSP90AB1 (3)
- ICAM1 (3)
- IL6ST (3)
- LAMA4 (3)
- LGR5 (3)
- LYL1 (3)
- MAPRE1 (3)
- MAPRE2 (3)
- MAPRE3 (3)
- NFKBIA (3)
- NGFR (3)
- RELA (3)
- SCARB1 (3)
- SLAMF7 (3)
- STAT1 (3)
- TFRC (3)
- TYRP1 (3)
Reactivities
- Human (1804)
- Mouse (1273)
- Rat (1154)
- Monkey (286)
- Dog (230)
- Hamster (21)
- Bovine (12)
- Rabbit (12)
- Zebrafish (11)
- C-term DDK (10)
- Sheep (9)
- Streptococcus Pyogenes (9)
- Xenopus (7)
- Chimpanzee (6)
- Goat (6)
- Porcine (6)
- Canine (5)
- Cow (4)
- Cynomolgus (4)
- Ferret (3)
- Primate (3)
- Baboon (2)
- Macaque (2)
- Marmoset (2)
- Pig (2)
- Saccharomyces cerevisiae (2)
- Drosophila melanogaster (1)
- Feline (1)
- Guinea Pig (1)
Antibody Hosts
Isotypes
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (27)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (13)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (10)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric hamster (Armenian) antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted antibody was made using the variable domain sequences of the original mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (965)
- Protein Kinase (374)
- Transmembrane (232)
- ES Cell Differentiation/IPS (220)
- Secreted Protein (173)
- Transcription Factors (131)
- Stem cell - Pluripotency (116)
- Protease (69)
- Adult stem cells (18)
- Embryonic stem cells (12)
- Stem cell relevant signaling - JAK/STAT signaling pathway (12)
- Cancer stem cells (8)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (7)
- Stem cell relevant signaling - Wnt Signaling pathway (7)
- Induced pluripotent stem cells (6)
- GPCR (4)
- Nuclear Hormone Receptor (3)
- Stem cell relevant signaling - DSL/Notch pathway (3)
- Ion Channels: Other (2)
- Phosphatase (2)
Pathways
- Pathways in cancer (241)
- Metabolic pathways (231)
- Pancreatic cancer (192)
- MAPK signaling pathway (176)
- ErbB signaling pathway (171)
- Progesterone-mediated oocyte maturation (171)
- Acute myeloid leukemia (170)
- Bladder cancer (160)
- Colorectal cancer (156)
- Focal adhesion (154)
- Neurotrophin signaling pathway (152)
- Chronic myeloid leukemia (149)
- Prostate cancer (147)
- Endometrial cancer (146)
- Glioma (145)
- Insulin signaling pathway (142)
- Chemokine signaling pathway (140)
- Melanoma (140)
- Natural killer cell mediated cytotoxicity (140)
- Non-small cell lung cancer (140)
- Regulation of actin cytoskeleton (135)
- mTOR signaling pathway (134)
- Renal cell carcinoma (133)
- Thyroid cancer (131)
- Long-term depression (121)
- Long-term potentiation (121)
- Vascular smooth muscle contraction (121)
- Fc gamma R-mediated phagocytosis (112)
- Glycerolipid metabolism (105)
- Toll-like receptor signaling pathway (90)
- Fc epsilon RI signaling pathway (87)
- Axon guidance (86)
- Oocyte meiosis (82)
- Systemic lupus erythematosus (81)
- T cell receptor signaling pathway (80)
- GnRH signaling pathway (79)
- Cell cycle (78)
- Gap junction (72)
- B cell receptor signaling pathway (65)
- Adherens junction (64)
- VEGF signaling pathway (62)
- NOD-like receptor signaling pathway (61)
- TGF-beta signaling pathway (59)
- Cell adhesion molecules (CAMs) (58)
- Prion diseases (57)
- Type II diabetes mellitus (56)
- Dorso-ventral axis formation (55)
- Alzheimer's disease (53)
- Melanogenesis (52)
- Arachidonic acid metabolism (41)
- Nucleotide excision repair (41)
- DNA replication (38)
- p53 signaling pathway (38)
- Homologous recombination (37)
- Mismatch repair (37)
- Starch and sucrose metabolism (35)
- Complement and coagulation cascades (33)
- Epithelial cell signaling in Helicobacter pylori infection (29)
- Small cell lung cancer (28)
- Jak-STAT signaling pathway (25)
- Pathogenic Escherichia coli infection (24)
- Apoptosis (23)
- Glycolysis / Gluconeogenesis (22)
- Pyruvate metabolism (22)
- Cysteine and methionine metabolism (21)
- Propanoate metabolism (20)
- Tight junction (20)
- Type I diabetes mellitus (20)
- Antigen processing and presentation (19)
- Adipocytokine signaling pathway (17)
- Cytokine-cytokine receptor interaction (17)
- Hematopoietic cell lineage (17)
- Butanoate metabolism (16)
- Taurine and hypotaurine metabolism (16)
- Alanine (15)
- Wnt signaling pathway (15)
- aspartate and glutamate metabolism (15)
- beta-Alanine metabolism (15)
- Viral myocarditis (14)
- Primary immunodeficiency (12)
- Huntington's disease (11)
- Hypertrophic cardiomyopathy (HCM) (11)
- Leukocyte transendothelial migration (11)
- Endocytosis (10)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (9)
- Dilated cardiomyopathy (9)
- Maturity onset diabetes of the young (9)
- Amyotrophic lateral sclerosis (ALS) (7)
- ECM-receptor interaction (6)
- RIG-I-like receptor signaling pathway (6)
- Vibrio cholerae infection (6)
- Fructose and mannose metabolism (5)
- Non-homologous end-joining (5)
- Calcium signaling pathway (4)
- Graft-versus-host disease (4)
- Allograft rejection (3)
- Autoimmune thyroid disease (3)
- Basal cell carcinoma (3)
- Cardiac muscle contraction (3)
- Cytosolic DNA-sensing pathway (2)
- Glycine (2)
- Lysosome (2)
- Nitrogen metabolism (2)
- Oxidative phosphorylation (2)
- Parkinson's disease (2)
- Purine metabolism (2)
- RNA degradation (2)
- Selenoamino acid metabolism (2)
- Spliceosome (2)
- serine and threonine metabolism (2)
- ABC transporters (1)
- Arginine and proline metabolism (1)
- Basal transcription factors (1)
- Base excision repair (1)
- Biosynthesis of unsaturated fatty acids (1)
- Citrate cycle (TCA cycle) (1)
- Cyanoamino acid metabolism (1)
- Fatty acid elongation in mitochondria (1)
- Fatty acid metabolism (1)
- Glutathione metabolism (1)
- Lysine degradation (1)
- Methane metabolism (1)
- Neuroactive ligand-receptor interaction (1)
- PPAR signaling pathway (1)
- Phenylalanine metabolism (1)
- Porphyrin and chlorophyll metabolism (1)
- Pyrimidine metabolism (1)
- Tryptophan metabolism (1)
- Ubiquitin mediated proteolysis (1)
- Valine (1)
- leucine and isoleucine degradation (1)